152 related articles for article (PubMed ID: 34856401)
21. Olfactory neuroblastoma (esthesioneuroblastoma) and esthesioneuroepithelioma: histologic and immunohistochemical study.
Taraszewska A; Czorniuk-Sliwa A; Dambska M
Folia Neuropathol; 1998; 36(2):81-6. PubMed ID: 9757618
[TBL] [Abstract][Full Text] [Related]
22. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.
Bell D; Saade R; Roberts D; Ow TJ; Kupferman M; DeMonte F; Hanna EY
Head Neck Pathol; 2015 Mar; 9(1):51-9. PubMed ID: 24806334
[TBL] [Abstract][Full Text] [Related]
23. Clinico-neuropathological features of isocitrate dehydrogenase 2 gene mutations in lower-grade gliomas.
Wang LM; Li Z; Piao YS; Cai YN; Zhang LY; Ge HJ; Xu WW; Lu DH
Chin Med J (Engl); 2019 Dec; 132(24):2920-2926. PubMed ID: 31833906
[TBL] [Abstract][Full Text] [Related]
24. Odorant receptor genes are expressed in olfactory neuroblastoma.
Gonzalez-Kristeller DC; Gutiyama LM; Campos AH; Soares FA; Brentani H; Malnic B
Genet Mol Res; 2013 Sep; 12(3):3479-87. PubMed ID: 24065686
[TBL] [Abstract][Full Text] [Related]
25. [Long-term experiences in the therapy of esthesioneuroblastoma].
Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
[TBL] [Abstract][Full Text] [Related]
26. [Study on pathological features and diagnosis, differential diagnosis of olfactory neuroblastoma].
Liu HG; Zhang SZ; He CY
Zhonghua Bing Li Xue Za Zhi; 2003 Oct; 32(5):432-6. PubMed ID: 14633455
[TBL] [Abstract][Full Text] [Related]
27. Olfactory neuroblastoma with focal ganglioneuroblastic differentiation: a case report with literature review.
Squillaci S
Pathologica; 2014 Jun; 106(2):61-6. PubMed ID: 25291869
[TBL] [Abstract][Full Text] [Related]
28. [Diagonistic and prognostic analysis of olfactory neuroblastoma].
Chen X; Sun Y; Ju J; Zheng Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Mar; 35(3):224-228. PubMed ID: 33794606
[No Abstract] [Full Text] [Related]
29. Olfactory neuroblastoma: detection of genomic imbalances by comparative genomic hybridization.
Szymas J; Wolf G; Kowalczyk D; Nowak S; Petersen I
Acta Neurochir (Wien); 1997; 139(9):839-44. PubMed ID: 9351988
[TBL] [Abstract][Full Text] [Related]
30. Ectopic primary olfactory neuroblastoma of the maxillary sinus.
Holmes M; Su SY; Bell D
Ann Diagn Pathol; 2016 Jun; 22():45-8. PubMed ID: 27180059
[TBL] [Abstract][Full Text] [Related]
31. The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia.
Chou WC; Lei WC; Ko BS; Hou HA; Chen CY; Tang JL; Yao M; Tsay W; Wu SJ; Huang SY; Hsu SC; Chen YC; Chang YC; Kuo KT; Lee FY; Liu MC; Liu CW; Tseng MH; Huang CF; Tien HF
Leukemia; 2011 Feb; 25(2):246-53. PubMed ID: 21079611
[TBL] [Abstract][Full Text] [Related]
32. Olfactory neuroblastoma: a review and update.
Faragalla H; Weinreb I
Adv Anat Pathol; 2009 Sep; 16(5):322-31. PubMed ID: 19700942
[TBL] [Abstract][Full Text] [Related]
33. IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies: Forty Molecularly Homogenous and Histologically Variable Cases With Favorable Outcome.
Glöss S; Jurmeister P; Thieme A; Schmid S; Cai WY; Serrette RN; Perner S; Ribbat-Idel J; Pagenstecher A; Bläker H; Keber U; Stadelmann C; Zechel S; Johann PD; Hasselblatt M; Paulus W; Thomas C; Dohmen H; Baumhoer D; Frank S; Agaimy A; Schüller U; Vasudevaraja V; Snuderl M; Liu CZ; Pfister DG; Jungbluth AA; Ghossein RA; Xu B; Capper D; Dogan S
Am J Surg Pathol; 2021 Sep; 45(9):1190-1204. PubMed ID: 34265800
[TBL] [Abstract][Full Text] [Related]
34. [Esthesioneuroblastomas. Clinico-pathological, immunohistochemical and nuclear ploidy study].
Paes de Lima A; Bellotti MS; Elsner B; Monteros Alvi M; Terzian A; Kaimen I
Medicina (B Aires); 1994; 54(5 Pt 1):415-22. PubMed ID: 7658976
[TBL] [Abstract][Full Text] [Related]
35. Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients.
Chotirat S; Thongnoppakhun W; Promsuwicha O; Boonthimat C; Auewarakul CU
J Hematol Oncol; 2012 Mar; 5():5. PubMed ID: 22397365
[TBL] [Abstract][Full Text] [Related]
36. Olfactory Neuroblastoma: Morphological Reappraisal and Molecular Insights with Quantum Leap in Clinical Perspectives.
Bell D; Brandea AI; Hanna EY
Curr Oncol Rep; 2023 Jan; 25(1):11-18. PubMed ID: 36449116
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of microvessel density and its correlation with clinicopathological features in human olfactory neuroblastoma.
Wu L; An J; Liu H
Clin Neuropathol; 2022; 41(3):114-121. PubMed ID: 35142285
[TBL] [Abstract][Full Text] [Related]
38. Transcription Factor Expression in Sinonasal Neuroendocrine Neoplasms and Olfactory Neuroblastoma (ONB): Hyams' Grades 1-3 ONBs Expand the Spectrum of SATB2 and GATA3-Positive Neoplasms.
Uccella S; Facco C; Chiaravalli AM; Pettenon F; La Rosa S; Turri-Zanoni M; Castelnuovo P; Cerati M; Sessa F
Endocr Pathol; 2022 Jun; 33(2):264-273. PubMed ID: 35522392
[TBL] [Abstract][Full Text] [Related]
39. SSTR2 Expression in Olfactory Neuroblastoma: Clinical and Therapeutic Implications.
Cracolici V; Wang EW; Gardner PA; Snyderman C; Gargano SM; Chiosea S; Singhi AD; Seethala RR
Head Neck Pathol; 2021 Dec; 15(4):1185-1191. PubMed ID: 33929681
[TBL] [Abstract][Full Text] [Related]
40. [Clinicopathologic study of sinonasal teratocarcinosarcoma and its contrast with olfactory neuroblastoma].
Li X; Liu HG; Xie XJ; Han YD; Li M
Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):458-64. PubMed ID: 19035117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
